Verde Operating Cycle from 2010 to 2025

Verde Science's Operating Cycle is decreasing with slightly volatile movements from year to year. Operating Cycle is predicted to flatten to 37.79. For the period between 2010 and 2025, Verde Science, Operating Cycle quarterly trend regression had mean deviation of  24.97 and range of 214. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
39.78
Current Value
37.79
Quarterly Volatility
53.28214492
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Verde Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verde Science's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.4 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 42.33, Dividend Yield of 0.0 or Days Sales Outstanding of 37.79. Verde financial statements analysis is a perfect complement when working with Verde Science Valuation or Volatility modules.
  
Build AI portfolio with Verde Stock
Check out the analysis of Verde Science Correlation against competitors.
For more detail on how to invest in Verde Stock please use our How to Invest in Verde Science guide.

Currently Active Assets on Macroaxis

When determining whether Verde Science offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verde Science's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verde Science Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verde Science Stock:
Check out the analysis of Verde Science Correlation against competitors.
For more detail on how to invest in Verde Stock please use our How to Invest in Verde Science guide.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verde Science. If investors know Verde will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verde Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.01
Return On Assets
(52.91)
The market value of Verde Science is measured differently than its book value, which is the value of Verde that is recorded on the company's balance sheet. Investors also form their own opinion of Verde Science's value that differs from its market value or its book value, called intrinsic value, which is Verde Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verde Science's market value can be influenced by many factors that don't directly affect Verde Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verde Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verde Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verde Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.